Varespladib - ≥98%, high purity , Phospholipase A2 group IIA inhibitor, CAS No.172732-68-2, Phospholipase A2 group IIA inhibitor

Item Number
V125011
Grouped product items
SKUSizeAvailabilityPrice Qty
V125011-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$107.90
V125011-10mg
10mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$187.90
V125011-50mg
50mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$602.90

Basic Description

Synonyms2-[[3-(2-Amino-2-oxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetic acid | DTXSID50169378 | 2-{[1-benzyl-3-(carbamoylcarbonyl)-2-ethyl-1H-indol-4-yl]oxy}acetic acid | A-001 | EN300-19110 | NCGC00346491-08 | FT-0659937 | Varespladib [USAN] | SB16
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological Mechanisms

Varespladib (LY 315920), a specifically designed indolic secretory phospholipase A2 (sPLA2) inhibitor, has shown promising results in animals and adults. Inhibition seems to be inversely related to the severity of gas exchange impairment.

Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionPhospholipase A2 group IIA inhibitor
Note5mg、10mg卖完停产,不再备货
Product Description

Varespladib (LY315920) is a potent and selective human non-pancreatic secretory phospholipase A2 (hnsPLA) inhibitor with IC50 of 7 nM.

Product Properties

ALogP2.8

Associated Targets(Human)

PLA2G2D Tchem Group IID secretory phospholipase A2 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PLA2G6 Tchem 85/88 kDa calcium-independent phospholipase A2 (7 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PLA2G1B Tchem Phospholipase A2 (3 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PLA2G10 Tchem Group 10 secretory phospholipase A2 (6 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PLA2G2F Tchem Group IIF secretory phospholipase A2 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PLA2G2A Tchem Phospholipase A2, membrane associated (10 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PLA2G5 Tchem Calcium-dependent phospholipase A2 (3 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PLA2G2E Tchem Group IIE secretory phospholipase A2 (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PLA2G2A Tchem Phospholipase A2 group IIA (1079 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G2E Tchem Group IIE secretory phospholipase A2 (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G10 Tchem Group X secretory phospholipase A2 (219 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G6 Tchem Calcium-independent phospholipase A2 (359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G2F Tchem Group IIF secretory phospholipase A2 (15 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G2D Tchem Group IID secretory phospholipase A2 (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G5 Tchem Phospholipase A2 group V (238 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G3 Tbio Group III secretory phopholipase A2 (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G12A Tbio Group XIIA secretory phospholipase A2 (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PLA2G1B Phospholipase A2 group 1B (227 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cavia porcellus (23802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G2A Phospholipase A2, membrane associated (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name 2-(1-benzyl-2-ethyl-3-oxamoylindol-4-yl)oxyacetic acid
INCHI InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25)
InChi Key BHLXTPHDSZUFHR-UHFFFAOYSA-N
Canonical SMILES CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N
Isomeric SMILES CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N
WGK Germany 3
PubChem CID 155815
Molecular Weight 380.39

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDateItem
A1917103Certificate of AnalysisJun 19, 2024 V125011
A1917102Certificate of AnalysisJun 19, 2024 V125011

Chemical and Physical Properties

SolubilityDMSO 76 mg/mL Water <1 mg/mL Ethanol <1 mg/mL

Safety and Hazards(GHS)

WGK Germany 3

Related Documents

References

1. Snyder DW, Bach NJ, Dillard RD, Draheim SE, Carlson DG, Fox N, Roehm NW, Armstrong CT, Chang CH, Hartley LW et al..  (1999)  Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI..  J Pharmacol Exp Ther,  288  (3): (1117-24).  [PMID:10027849] [10.1021/op500134e]
2. Sanford M, McCormack PL.  (2011)  Varespladib..  Am J Cardiovasc Drugs,  11  (2): (137-43).  [PMID:21446779] [10.1021/op500134e]
3. Draheim SE, Bach NJ, Dillard RD, Berry DR, Carlson DG, Chirgadze NY, Clawson DK, Hartley LW, Johnson LM, Jones ND et al..  (1996)  Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides..  J Med Chem,  39  (26): (5159-75).  [PMID:8978844] [10.1021/op500134e]

Solution Calculators